Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Okabe

Showing results (71-80 of 518) with videos related to

Pageof 52
Sort By:
Blood|May 1, 1994
p53 gene mutation in the chronic phase was not detected in the myeloid crisis of a chronic myelocytic leukemia caseM Kurosawa, M Okabe, Y Kunieda, et al.
Gan|August 1, 1979
Potentiation of L1210 murine leukemia vaccine in vivo by levamisoleT Kataoka, S Tsukagoshi, Y Sakurai, et al.
Japanese Journal of Pharmacology|August 1, 1997
Platelet-derived growth factor blocks the cell-cycle transition from the G0 to G1 phase in subcultured angiogenic endothelial cells in rat thoracic aortaI Kimura, H Tsuneki, M Okabe, et al.
Human Cell|January 22, 1998
Evolutionarily conserved mechanisms regulating neural development: lessons from the development of Drosophila peripheral nervous systemsH Okano, M Okabe, A Taguchi, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1975
Relationship between antitumor effect of polysaccharides and biogenic amines in tumor tissuesT Ikekawa, M Sano, M Okabe, et al.
Kaibogaku Zasshi. Journal of Anatomy|January 25, 2002
Rapid and simple fixation-staining technique of fresh frozen cryostat sections for SIMS microscopyH Li, M Okabe, T Yoshida, et al.
Journal of Pharmacobio-Dynamics|February 1, 1986
Potent platelet antiaggregant action of an antiarrhythmic peptide (AAP)Y Kohama, K Iwabuchi, M Okabe, et al.
Current Topics in Developmental Biology|January 19, 1999
Green fluorescent protein (GFP) as a vital marker in mammalsM Ikawa, S Yamada, T Nakanishi, et al.
Annals of Hematology|August 1, 1995
Analysis of the p53 gene mutations in acute myelogenous leukemia: the p53 gene mutations associated with a deletion of chromosome 17M Kurosawa, M Okabe, Y Kunieda, et al.
Anti-Cancer Drugs|April 1, 1993
Reduced bone marrow toxicity of KW-2149, a mitomycin C derivative, in miceT Ashizawa, M Okabe, K Gomi, et al.
Pageof 52

Showing results (71-80 of 518) with videos related to

Sort By:
Pageof 52
Blood|May 1, 1994
p53 gene mutation in the chronic phase was not detected in the myeloid crisis of a chronic myelocytic leukemia caseM Kurosawa, M Okabe, Y Kunieda, et al.
Gan|August 1, 1979
Potentiation of L1210 murine leukemia vaccine in vivo by levamisoleT Kataoka, S Tsukagoshi, Y Sakurai, et al.
Japanese Journal of Pharmacology|August 1, 1997
Platelet-derived growth factor blocks the cell-cycle transition from the G0 to G1 phase in subcultured angiogenic endothelial cells in rat thoracic aortaI Kimura, H Tsuneki, M Okabe, et al.
Human Cell|January 22, 1998
Evolutionarily conserved mechanisms regulating neural development: lessons from the development of Drosophila peripheral nervous systemsH Okano, M Okabe, A Taguchi, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1975
Relationship between antitumor effect of polysaccharides and biogenic amines in tumor tissuesT Ikekawa, M Sano, M Okabe, et al.
Kaibogaku Zasshi. Journal of Anatomy|January 25, 2002
Rapid and simple fixation-staining technique of fresh frozen cryostat sections for SIMS microscopyH Li, M Okabe, T Yoshida, et al.
Journal of Pharmacobio-Dynamics|February 1, 1986
Potent platelet antiaggregant action of an antiarrhythmic peptide (AAP)Y Kohama, K Iwabuchi, M Okabe, et al.
Current Topics in Developmental Biology|January 19, 1999
Green fluorescent protein (GFP) as a vital marker in mammalsM Ikawa, S Yamada, T Nakanishi, et al.
Annals of Hematology|August 1, 1995
Analysis of the p53 gene mutations in acute myelogenous leukemia: the p53 gene mutations associated with a deletion of chromosome 17M Kurosawa, M Okabe, Y Kunieda, et al.
Anti-Cancer Drugs|April 1, 1993
Reduced bone marrow toxicity of KW-2149, a mitomycin C derivative, in miceT Ashizawa, M Okabe, K Gomi, et al.
Pageof 52